March 01, 1999
Meetings & Conventions: Short Cuts March 1999 Current Issue
March 1999
AppleShort Cuts:

Worth a shot: The Food and Drug Administration recently approved a vaccine against Lyme disease, the tick-borne illness that causes symptoms ranging from fatigue, headache and rash to arthritis, nervous-system disfunctions and even heart problems. The vaccine, developed by SmithKline Beecham Biologicals, can be used by people between the ages of 15 and 70. It’s given in three doses: The initial dose, a second dose a month later, then a third 12 months after the first. The duration of immunity is unknown, as is the need for boosters, according to a report on the vaccine released by the Centers for Disease Control and Prevention.

Shot or no, the CDC recommends these preventative measures: Avoid tick habitats (woodsy or grassy areas, primarily in the Northeast, North Central states and northern California), wear protective clothing, use tick repellents and promptly remove attached ticks.

Back to Current Issue index | Back to Short Cuts index
M&C Home Page
Current Issue | Events Calendar | Newsline | Incentive News | Meetings Market Report
Editorial Libraries | CVB Links | Reader Survey | Hot Dates | Contact M&C